1.86
Schlusskurs vom Vortag:
$1.80
Offen:
$1.82
24-Stunden-Volumen:
263.44K
Relative Volume:
0.51
Marktkapitalisierung:
$180.88M
Einnahmen:
$32.38M
Nettoeinkommen (Verlust:
$-21.64M
KGV:
-7.3897
EPS:
-0.2517
Netto-Cashflow:
$-13.78M
1W Leistung:
+3.33%
1M Leistung:
-15.45%
6M Leistung:
-36.30%
1J Leistung:
-6.06%
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
STXS
Stereotaxis Inc
|
1.86 | 175.05M | 32.38M | -21.64M | -13.78M | -0.2517 |
|
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2022-07-12 | Eingeleitet | Aegis Capital | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2022-01-05 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | Loop Capital | Buy |
| 2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-08 | Eingeleitet | Northland Capital | Outperform |
| 2020-04-09 | Eingeleitet | Cowen | Outperform |
| 2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris - Traders Union
[EFFECT] Stereotaxis, Inc. SEC Filing - Stock Titan
Aug Big Picture: Is Stereotaxis Inc being accumulated by smart moneyWeekly Earnings Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Stereotaxis (STXS) Announces First Robotic MAGiC Sweep Catheter Procedure at Deborah Heart and Lung Center - MSN
Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview - Traders Union
Analyst Calls: Can Stereotaxis Inc keep up with sector leaders2026 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Stereotaxis Inc. (STXS) reports Q4 loss, lags revenue estimates - MSN
Stereotaxis (NYSE American: STXS) registers $79.6M unsold securities, adds $42.1M ATM balance - Stock Titan
Stereotaxis (STXS) to Participate in BTIG Hosted Virtual Meeting - GuruFocus
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS) - Seeking Alpha
Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN
Stereotaxis Inc. 2025 Annual Report: Robotic Magnetic Navigation Systems, Strategic Partnerships, and Market Overview - Minichart
Stereotaxis (NYSE: STXS) details 2025 backlog, APT deal and catheter shift - Stock Titan
Stereotaxis 10-K: $32.4M Revenue, $(0.25) EPS - TradingView
32.4 million revenue surges over 20 percent with regulatory wins, Stereotaxis asserts - Traders Union
Stereotaxis (STXS) Q4 Earnings: EPS Beats, Revenue Misses - GuruFocus
Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ... By GuruFocus - Investing.com Canada
Stereotaxis (STXS) Achieves Regulatory Milestones and Revenue Gr - GuruFocus
Stereotaxis Q4 Earnings Call Highlights - MarketBeat
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - Bitget
Stereotaxis earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Stereotaxis (STXS) Projects Strong Revenue Growth by 2026 - GuruFocus
STXS Q4 Revenue Misses Expectations; Strong Backlog Reported - GuruFocus
Stereotaxis reports 20% revenue growth - The Business Journals
Surgical robotics firm Stereotaxis Q4 revenue jumps - TradingView
Stereotaxis (NYSE: STXS) posts 20% 2025 revenue growth and eyes $40M+ in 2026 - Stock Titan
Stereotaxis Q4 Earnings Summary & Key Takeaways - Benzinga
Stereotaxis Reports 2025 Full Year Financial Results - ChartMill
Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET - Traders Union
Surgical robotics firm Stereotaxis aims to top $40M revenue in 2026 - Stock Titan
Aug Weekly: Should I buy Stereotaxis Inc stock nowJuly 2025 Chart Watch & Fast Entry High Yield Tips - baoquankhu1.vn
AI Robot in Heart Treatment Market Is Going to Boom | Major Giants Intuitive Surgical, Stereotaxis, Auris Health - openPR.com
Stereotaxis (STXS) Set to Release Q4 Earnings with Revenue Growt - GuruFocus
Preview: Stereotaxis's Earnings - Benzinga
Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update - Defense World
Treasury Yields: Should value investors consider Stereotaxis IncTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
STXS SEC FilingsStereotaxis Ord 10-K, 10-Q, 8-K Forms - Stock Titan
Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union
Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat
STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com
Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - Revista ADVFN
Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union
Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat
STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru
Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat
Fed Watch: Does Stereotaxis Inc align with a passive investing strategyQuarterly Profit Report & Risk Controlled Stock Alerts - baoquankhu1.vn
Will Stereotaxis Inc. stock recover after earningsMarket Volume Summary & Safe Entry Trade Reports - mfd.ru
Why Stereotaxis Inc. stock is favored by top institutionsQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewswire
Robotic surgery firm Stereotaxis to reveal 2025 results March 9 - Stock Titan
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):